Literature DB >> 18510371

Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa.

Malcolm S Buchanan1, Anthony R Carroll, Deborah Wessling, Michael Jobling, Vicky M Avery, Rohan A Davis, Yunjiang Feng, Yafeng Xue, Linda Oster, Tomas Fex, Johanna Deinum, John N A Hooper, Ronald J Quinn.   

Abstract

Bioassay-guided fractionation of a CH2Cl2/MeOH extract of the sponge Suberea clavata using the serine protease factor XIa to detect antithrombotic activity led to the isolation of the new marine natural products, clavatadines A and B. Clavatadines A and B inhibited factor XIa with IC50's of 1.3 and 27 microM, respectively. A crystal structure of protein-inhibitor (clavatadine A) complex was obtained and revealed interesting selective binding and irreversible inhibition of factor XIa. The cocrystal structure provides guidance for the design and synthesis of future factor XIa inhibitors as antithrombotic agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18510371     DOI: 10.1021/jm800314b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

Review 1.  Factor XI and XII as antithrombotic targets.

Authors:  Felicitas Müller; David Gailani; Thomas Renné
Journal:  Curr Opin Hematol       Date:  2011-09       Impact factor: 3.284

2.  A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits.

Authors:  Pancras C Wong; Earl J Crain; Carol A Watson; William A Schumacher
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

3.  Lithothamnin A, the first bastadin-like metabolite from the red alga Lithothamnion fragilissimum.

Authors:  Albert W W Van Wyk; Karina M Zuck; Tawnya C McKee
Journal:  J Nat Prod       Date:  2011-04-13       Impact factor: 4.050

Review 4.  Is it time for artificial intelligence to predict the function of natural products based on 2D-structure.

Authors:  Miaomiao Liu; Peter Karuso; Yunjiang Feng; Esther Kellenberger; Fei Liu; Can Wang; Ronald J Quinn
Journal:  Medchemcomm       Date:  2019-06-06       Impact factor: 3.597

5.  High-resolution crystal structures of factor XIa coagulation factor in complex with nonbasic high-affinity synthetic inhibitors.

Authors:  Xavier Fradera; Bert Kazemier; Emma Carswell; Andrew Cooke; Arthur Oubrie; William Hamilton; Maureen Dempster; Stephan Krapp; Susanna Nagel; Anja Jestel
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-03-27

Review 6.  Future prospects for contact factors as therapeutic targets.

Authors:  David Gailani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

Review 7.  Recent advances in the discovery and development of factor XI/XIa inhibitors.

Authors:  Rami A Al-Horani; Daniel K Afosah
Journal:  Med Res Rev       Date:  2018-05-04       Impact factor: 12.944

8.  Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site.

Authors:  Rajesh Karuturi; Rami A Al-Horani; Shrenik C Mehta; David Gailani; Umesh R Desai
Journal:  J Med Chem       Date:  2013-03-18       Impact factor: 7.446

9.  Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa.

Authors:  Rami A Al-Horani; Pooja Ponnusamy; Akul Y Mehta; David Gailani; Umesh R Desai
Journal:  J Med Chem       Date:  2013-01-28       Impact factor: 7.446

Review 10.  Factor XIa inhibitors: A review of the patent literature.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Expert Opin Ther Pat       Date:  2016       Impact factor: 6.674

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.